In acute GVHD (aGVHD) patients, there is a marked upregulation in the expression of CD86 (an activation marker) and CD20 (a marker of mature B cells), which mirrors the changes seen in B cells during infections.37 This evidence concerns the gene CD86 and acute graft versus host disease.